Cite
HARVARD Citation
Eun, J. et al. (2023). Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib. Cancer communications. 43 (4), pp. 455-479. [Online].